Product Liability and Mass Torts

Claim File Sampling and Analysis

Claim File Sampling and Analysis

It is often the case in product liability and mass tort cases that relevant data are available in paper files only. Proper analysis of these data may require that it first be manually coded to convert the information into an electronic database.
 
NERA has extensive experience with coding of this type. Our experts have mastered all aspects of capturing, coding, and organizing information from claims files to generate electronic databases. This process begins with the development of a coding protocol that establishes clear rules (avoiding error or bias introduced by human subjectivity), and a system of double-entry and reconciliation to ensure accuracy. We manage teams of coders, operating round-the-clock shifts (if necessary) to ensure the project is completed in a timely and efficient manner.
 
We have coded large samples of personal injury and property damage claims in a number of areas, including asbestos, breast implants, medical devices, food poisoning, and police incidence reports. Depending on the type of information to be entered or source file used, we ensure that the claim coders have the requisite skills to accurately code the information. For example, we have used paralegals to code claimant depositions and health professionals to code medical files.

We use rigorous sampling and statistical techniques to determine whether a sample is representative of the population and have testified about sampling methodologies. Our statistical analyses of claim files have been used in insurance coverage disputes, bankruptcy actions and settlement negotiations.

Name Title Location Phone Email
Lucy P. Allen Managing Director New York City +1 212 345 5913 lucy.allen@nera.com
Dr. Anne Gron Managing Director Chicago +1 312 573 2850 anne.gron@nera.com
Dr. Denise Neumann Martin Managing Director New York City +1 212 345 5296 denise.martin@nera.com
Dr. Faten Sabry Managing Director
Bankruptcy Practice Chair
New York City
London
+1 212 345 3285
+44 20 7659 8618
faten.sabry@nera.com
Dr. Kent Van Liere Managing Director Denver
San Francisco
+1 303 357 4782
+1 415 291 1010
kent.van.liere@nera.com
Mary Elizabeth C. Stern Director White Plains, NY +1 914 448 4054 mary.elizabeth.stern@nera.com
Drew Claxton Associate Director New York City +1 212 345 3442 drew.claxton@nera.com
Timothy McKenna Associate Director New York City +1 212 345 5503 timothy.mckenna@nera.com
Dr. Stephanie Plancich Associate Director New York City +1 212 345 7719 stephanie.plancich@nera.com
Title Type Author
Snapshot of Recent Trends in Asbestos Litigation: 2017 Update Report Mary Elizabeth C. Stern and Lucy P. Allen
Asbestos: Economic Assessment of Bans and Declining Production and Consumption Report By Lucy P. Allen, Mary Elizabeth C. Stern, Jorge Baez, and Frank George
Snapshot of Recent Trends in Asbestos Litigation: 2014 Update Report By Mary Elizabeth C. Stern and Lucy P. Allen
Where are Mesothelioma Claims Heading? Working Paper By Dr. Faten Sabry et al.
Forecasting Claims in an Era of Tort Reform Published Article By Dr. Faten Sabry and former NERA Senior Vice President Dr. Fred Dunbar